Alzheon, Inc. is a biotechnology company dedicated to developing innovative treatments for Alzheimer's disease. The company focuses on creating therapeutics that aim to slow or halt the progression of Alzheimer's and potentially prevent the onset of clinical symptoms.
Company Values
Alzheon stands out with its commitment to an oral anti-amyloid treatment, currently the only one in Phase 3 testing, and its application of precision medicine to neurodegenerative diseases.